Literature DB >> 9931047

One-step direct assay for mature-type adrenomedullin with monoclonal antibodies.

H Ohta1, T Tsuji, S Asai, K Sasakura, H Teraoka, K Kitamura, K Kangawa.   

Abstract

Adrenomedullin (AM) is a potent hypotensive peptide. Plasma contains mature-type AM (m-AM), which is amidated at the carboxy terminus, and an intermediate, AM-Gly. We developed a one-step two-site IRMA specific for determining human m-AM with monoclonal antibodies. The detection limit was 0.5 pmol/L, and the working range (CV <15%) was 1-300 pmol/L. Dilution of plasma samples showed good linearity. The recovery of added AM was 91-118%. The intra- and interassay imprecision values (CVs) were 4.4-8.2% and 5.5-8.3%, respectively. The assay had no cross-reactivity with AM-Gly or other peptides similar to AM. The mean (+/- SD) plasma human m-AM concentration of 61 healthy subjects was 1.18 +/- 0.65 pmol/L. In conclusion, our IRMA makes it possible to specifically measure m-AM, using a small amount of plasma sample (0.2 mL) by a one-step overnight assay without prior extraction. Our simplified method would be suitable for clinical studies on AM, especially when large numbers of samples must be processed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931047

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Modulation of plasma adrenomedullin by epinephrine infusion during head up tilt.

Authors:  Andreas Roessler; Nandu Goswami; Bernd Haditsch; Helmut Hinghofer-Szalkay
Journal:  Eur J Appl Physiol       Date:  2010-10-06       Impact factor: 3.078

2.  Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling.

Authors:  K Tambara; M Fujita; N Nagaya; S Miyamoto; A Iwakura; K Doi; G Sakaguchi; K Nishimura; K Kangawa; M Komeda
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

3.  Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomy.

Authors:  Pang-Hu Zhou; Lei Shi; Wei Hu; Xiao-Bin Zhang; Wei Wang; Li-Jun Zhang
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

4.  Two molecular forms of adrenomedullin in congenital heart disease.

Authors:  K Watanabe; T Nishikimi; M Takamuro; K Yasuda; Y Ishikawa; S Tanabe; O Yamada; N Nagaya; H Matsuoka; K Kangawa; S Echigo
Journal:  Pediatr Cardiol       Date:  2003-09-04       Impact factor: 1.655

5.  Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.

Authors:  Kazuhide Watanabe; Yasuhiro Hasegawa; Hiroshi Yamashita; Kazue Shimizu; Yuanying Ding; Mayumi Abe; Hideki Ohta; Keiichi Imagawa; Kanji Hojo; Hideo Maki; Hikaru Sonoda; Yasufumi Sato
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  Increased adrenomedullin immunoreactivity and mRNA expression in coronary plaques obtained from patients with unstable angina.

Authors:  T Ishikawa; K Hatakeyama; T Imamura; K Ito; S Hara; H Date; Y Shibata; Y Hikichi; Y Asada; T Eto
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

7.  Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.

Authors:  Shinya Ashizuka; Haruhiko Inatsu; Toshihiro Kita; Kazuo Kitamura
Journal:  Dig Dis Sci       Date:  2015-10-15       Impact factor: 3.199

8.  Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial.

Authors:  Toshihiro Kita; Yoshikazu Kaji; Kazuo Kitamura
Journal:  Drug Des Devel Ther       Date:  2020-01-06       Impact factor: 4.162

Review 9.  Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases.

Authors:  Toshihiro Kita; Kazuo Kitamura
Journal:  Hypertens Res       Date:  2022-01-06       Impact factor: 5.528

10.  Development of Long-Acting Human Adrenomedullin Fc-Fusion Proteins.

Authors:  Sayaka Nagata; Motoo Yamasaki; Nobuko Kuroishi; Kazuo Kitamura
Journal:  Biology (Basel)       Date:  2022-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.